Paul Medeiros is a member of Kolltan’s Board of Directors.Mr. Medeiros is Head of Corporate and Business Development at Mundipharma International.Previously, he served as Senior Vice President and Chief Business Officer at AVI BioPharma (now, Sarepta Therapeutics).Prior to this, Mr. Medeiros served as Vice President, Global Licensing and Strategic Alliances for Schering-Plough where he led worldwide product licensing and strategic partnering initiatives in specialist product categories.Mr. Medeiros began his biopharmaceutical career at Merck & Company, where he held positions in new product planning and worldwide marketing.Mr. Medeiros holds an A.B. with honors from Brown University and an M.B.A. from Columbia Business School.